Pular para o conteúdo
Lúpus eritematoso discoide
ORPHA:90281CID-10 · L93.0CID-11 · EB51.0DOENÇA RARA
DermatológicoInício infantil
Também conhecida comoLúpus discoideLES

Doença crônica e autoimune da pele que se manifesta com erupção cutânea vermelha e descamativa, mais frequentemente encontrada no rosto, orelhas e couro cabeludo; essas lesões geralmente levam a cicatrizes permanentes e despigmentação. Os pacientes podem apresentar lesões com ou sem outros sintomas ou anticorpos sugestivos de lúpus eritematoso sistêmico (LES).

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O **lúpus eritematoso discoide** é uma doença autoimune e de longa duração que atinge a pele, provocando manchas avermelhadas e descamativas no rosto, orelhas e couro cabeludo. Com o passar do tempo, as lesões podem causar cicatrizes permanentes, áreas esbranquiçadas e queda definitiva de cabelo nas regiões inflamadas. O diagnóstico é estabelecido principalmente pela avaliação médica das manchas e pelo resultado de biópsia cutânea com teste de banda lúpica positivo. No Brasil, o Ministério da Saúde disponibiliza o PCDT de lúpus eritematoso sistêmico como documento relacionado, e o SUS entrega opções farmacológicas como azatioprina e ciclosporina.

📋
Informacoes curadas por IA — podem conter imprecisoes

Doença crônica e autoimune da pele que se manifesta com erupção cutânea vermelha e descamativa, mais frequentemente encontrada no rosto, orelhas e couro cabeludo; essas lesões geralmente levam a cicatrizes permanentes e despigmentação. Os pacientes podem apresentar lesões com ou sem outros sintomas ou anticorpos sugestivos de lúpus eritematoso sistêmico (LES).

Pesquisas ativas
11 ensaios
41 total registrados no ClinicalTrials.gov
Publicações científicas
1.833 artigos
Último publicado: 2026
Medicamentos
3 com registro
Azatioprina, Betaloan SUIK (BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE), Dyural 40 Kit (METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL)

Tem tratamento?

✓ 3 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
AZATIOPRINABETALOAN SUIK (BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE)DYURAL 40 KIT (METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL)

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
30.0
Worldwide
Início
Adolescent
+ adult, childhood, elderly
🏥
SUS: Cobertura parcialScore: 50%
1 medicamento CEAFCID-10: L93.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

55%prev.
Placa eritematosa
Frequente (79-30%)
55%prev.
Teste de banda lúpica positivo
Frequente (79-30%)
55%prev.
Hipopigmentação da pele
Frequente (79-30%)
55%prev.
Alopecia cicatricial do couro cabeludo
Frequente (79-30%)
55%prev.
Telangiectasia da pele
Frequente (79-30%)
55%prev.
Hiperceratose folicular
Frequente (79-30%)
10sintomas
Frequente (8)
Ocasional (1)
Muito raro (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 10 características clínicas mais associadas, ordenadas por frequência.

Placa eritematosaErythematous plaque
Frequente (79-30%)55%
Teste de banda lúpica positivoPositive lupus band test
Frequente (79-30%)55%
Hipopigmentação da peleHypopigmentation of the skin
Frequente (79-30%)55%
Alopecia cicatricial do couro cabeludoScarring alopecia of scalp
Frequente (79-30%)55%
Telangiectasia da peleTelangiectasia of the skin
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.833PubMed
Últimos 10 anos200publicações
Pico202583 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 37
2Fase 221
1Fase 16
·Pré-clínico7
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 41 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Lúpus eritematoso discoide

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 21 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

41 ensaios clínicos encontrados, 11 ativos.

Distribuição por fase
NCT07840287 · A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous …Em breve
PHASE3🇩🇪 Alemanha · 🇺🇸 Estados Unidos
NCT07557927 · A Multicentre, Randomised, Double-blind, Positive-control Cl…Em breve
PHASE2🇨🇳 China
NCT06015737 · A Phase III Study to Investigate the Efficacy and Safety of …Ativo
PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇺 Austrália +29
NCT05540327 · The Willow LTE Study With M5049 in Participants With SCLE, D…Ativo
PHASE2🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇺 Austrália +19
NCT05531565 · A 2-Part Study to Learn Whether Litifilimab (BIIB059) Inject…Ativo
PHASE2, PHASE3🇧🇷 Brasil · 🇦🇷 Argentina · 🇧🇪 Bélgica +27
NCT06980805 · A Study to Assess the Safety, Tolerability, and Efficacy of …Ativo
PHASE2🇦🇷 Argentina · Bulgaria · 🇨🇦 Canadá +10
NCT04857034 · A Study to Evaluate Efficacy and Safety of Deucravacitinib i…Ativo
PHASE2🇦🇷 Argentina · 🇦🇺 Austrália · 🇫🇷 França +5
NCT05162586 · The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE)…Concluído
PHASE2🇧🇷 Brasil · 🇦🇷 Argentina · 🇦🇺 Austrália +19
NCT06013995 · A Study to Investigate the Safety, Tolerability, Drug Levels…Concluído
PHASE1🇦🇷 Argentina · Bulgaria · 🇩🇪 Alemanha +5
NCT04908280 · Study of Ruxolitinib Cream for the Treatment of Discoid Lupu…Concluído
PHASE2🇺🇸 Estados Unidos
NCT05362188 · Topical Nicotinamide in Treatment of DLEConcluído
EARLY_PHASE1🇪🇬 Egito
NCT02656082 · Targeted Therapy Using Intradermal Injection of Etanercept f…Concluído
PHASE2🇬🇧 Reino Unido
NCT02125695 · Pilot Tape Harvesting StudyConcluído
🇺🇸 Estados Unidos
NCT02034344 · A Study of Skin and Systemic Biomarkers In Patients With Act…Concluído
🇩🇪 Alemanha · 🇲🇽 México · 🇵🇱 Polônia +3
NCT01923415 · A Non-drug Study Profiling Cutaneous LupusConcluído
🇵🇱 Polônia · 🇺🇸 Estados Unidos
NCT01597050 · Safety and Efficacy of Topical R333 in Patients With Discoid…Concluído
PHASE2🇨🇦 Canadá · 🇺🇸 Estados Unidos
NCT01858792 · A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS100…Concluído
NCT01300208 · To Evaluate the Preliminary Safety, Tolerability, Pharmacoki…Concluído
PHASE2🇺🇸 Estados Unidos
NCT00708916 · Safety Study of Clinical and Immune Effects of Phosphodieste…Concluído
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT01845740 · Phase Ib Study of SC Milatuzumab in SLEConcluído
PHASE1🇺🇸 Estados Unidos
NCT00625521 · Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment …Concluído
PHASE2🇸🇪 Suécia
NCT00691769 · Expression of Fas Protein in Skin Biopsies of Participants W…Concluído
🇺🇸 Estados Unidos
NCT00608673 · Comparing the Therapeutic Efficacy of Pimecrolimus Cream Wit…Concluído
NAIran
NCT00001680 · A Pilot Trial of Topical Thalidomide for the Management of C…Concluído
PHASE2🇺🇸 Estados Unidos
NCT00625157 · Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment …Concluído
PHASE2🇩🇰 Dinamarca
NCT03178188 · Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid …UNKNOWN
PHASE2, PHASE3Thailand
NCT00797784 · The Safety and Efficacy of Etanercept (Enbrel®) for the Trea…UNKNOWN
PHASE2🇺🇸 Estados Unidos
NCT05591222 · Study of Daxdilimab (HZN-7734) in Participants With Moderate…Encerrado
PHASE2🇧🇷 Brasil · 🇦🇷 Argentina · Bulgaria +8
NCT03958955 · Efficacy and Safety of Delgocitinib Cream in Discoid Lupus E…Encerrado
PHASE2🇩🇰 Dinamarca · 🇫🇷 França · 🇩🇪 Alemanha +1
NCT03159936 · Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythe…Encerrado
EARLY_PHASE1🇺🇸 Estados Unidos
NCT02428309 · Autologous Polyclonal Tregs for LupusEncerrado
PHASE1🇺🇸 Estados Unidos
NCT01466725 · A Research Study to Assess if CC-930 is Safe in Treating Sub…Encerrado
PHASE2🇺🇸 Estados Unidos
NCT01407679 · Efficacy and Safety of Oral Alitretinoin (Toctino®) in the T…Encerrado
PHASE2🇩🇪 Alemanha
NCT01164917 · Safety Study of AMG 811 in Subjects With Discoid Lupus Eryth…Encerrado
PHASE1🇺🇸 Estados Unidos
NCT03866317 · A Study to Assess the Safety and Efficacy of Secukinumab in …Cancelado
PHASE2🇺🇸 Estados Unidos
NCT00308204 · Discoid Lupus Erythematosus of the Scalp and a Trial of Biol…Cancelado
PHASE2🇺🇸 Estados Unidos
NCT00222183 · Cutaneous Lupus Erythematosus and ElidelCancelado
NA🇩🇪 Alemanha
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
610 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 610

#1

Comorbidities in Discoid Lupus: A Systematic Review and Meta-analysis of Prevalence and Association.

Dermatology and therapy2026 Mar 18

Discoid lupus erythematosus (DLE) is a chronic inflammatory scarring alopecia that may be accompanied by a broad range of systemic and extracutaneous comorbidities. However, the prevalence and magnitude of these associations have not been comprehensively quantified. Our objective was to systematically evaluate the prevalence and associated risk of comorbidities in patients with discoid lupus erythematosus. We conducted a systematic review and random-effects meta-analysis in accordance with PRISMA 2020 guidelines, prospectively registered in PROSPERO (CRD420250656067). MEDLINE and Embase were searched from inception to June 2025. Observational studies reporting comorbidities in patients with DLE were included. Pooled prevalence estimates and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models. Between-study heterogeneity was assessed using the I2 statistic. Sensitivity analyses excluding small studies (n < 50) were performed for prevalence outcomes, whereas the robustness of association analyses was assessed qualitatively owing to the limited number of contributing studies. Methodological quality was evaluated using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist. In total, 25 studies were included. Pooled prevalence estimates indicated a high frequency of systemic lupus erythematosus (SLE) (22.0%), hypertension (24.3%), depression (38.8%), and hypothyroidism (12.4%) among patients with DLE. Sensitivity analyses showed stable prevalence estimates for SLE and hypertension, with moderate variability for hypothyroidism and depression. Meta-analyses of case-control studies demonstrated significant associations between DLE and cardiovascular disease (OR 3.85, 95% CI 1.67-8.88), hypothyroidism (OR 2.55, 95% CI 1.79-3.61), hypertension (OR 2.22, 95% CI 1.91-2.58), depression (OR 2.21, 95% CI 1.71-2.85), and anxiety (OR 2.40, 95% CI 1.40-4.11). Associations with type 2 diabetes were more modest, while smoking was not significantly associated. Most association analyses were based on a limited number of studies. Patients with discoid lupus erythematosus exhibit a substantial burden of systemic, cardiometabolic, endocrine, and psychiatric comorbidities. While prevalence estimates were generally consistent, associations should be interpreted cautiously owing to limited available evidence. These findings highlight the importance of comprehensive clinical assessment and multidisciplinary management of patients with DLE. The study protocol was prospectively registered in PROSPERO (CRD420250656067).

#2

Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.

Annals of plastic surgery2026 Mar 19

Invasive and minimally invasive cosmetic procedures in patients with autoimmune or inflammatory skin disorders can carry an increased risk of surgical site infection, disease exacerbation, atrophic/hypertrophic scarring, or suboptimal cosmetic results. As facial procedures continue to rise in popularity, increasing complications are being reported in association with underlying dermatologic disease. In this review, we aim to bring attention to these dermatologic conditions and the potential challenges that they pose to the facial plastic surgeon. A comprehensive literature search was conducted across PubMed, Embase, and MEDLINE for articles published before January 2025 describing one or more patients with complications following facial or scalp procedures relating to a pre-existing or underlying dermatologic disorder or systemic condition with dermatologic manifestations. Articles were screened according to PRISMA guidelines, and data extraction included dermatologic disease diagnosis and severity, facial procedure performed, perioperative or postoperative complications, and resolution/treatment. Our search criteria identified 2452 articles; 53 articles met the inclusion criteria. In a total of 469 patients with pre-existing dermatologic conditions, mild-severe complications were reported after blepharoplasty (41/469, 8.7%), rhinoplasty (254/469, 54.2%), rhytidectomy (25/469, 5.3%), hair transplantation (37/469, 7.9%), cosmetic injections (35/469, 7.5%), lasers (15/469, 3.2%), and microneedling (50/469, 10.7%). Dermatologic disorders included acne, atopic dermatitis, frontal fibrosing alopecia, lichen planopilaris, rosacea, and vitiligo; systemic conditions with dermatologic manifestations included Ehlers-Danlos syndrome, sarcoidosis, scleroderma, and systemic or discoid lupus erythematosus. Complications ranged from mild postoperative disease exacerbation to severe hypertrophic scarring, ulcerations, and wound healing defects. The existing literature, while limited to case reports and small case series, demonstrates potential risks following facial procedures in patients with dermatologic disorders. This review highlights the importance of consideration of dermatologic disease in facial surgery planning and decision-making and summarizes effective strategies to minimize any potential risk.

#3

Treatment of discoid lupus erythematosus with crisaborole.

The Journal of dermatological treatment2026 Dec

Discoid lupus erythematosus (DLE) is a chronic autoimmune skin disorder that primarily affects sun-exposed areas and may lead to permanent scarring and dyspigmentation if inadequately treated. Therapeutic options for DLE remain limited, and long-term use of topical corticosteroids or calcineurin inhibitors is often constrained by adverse effects, particularly on facial skin. This report aims to describe the clinical response of facial DLE to topical crisaborole treatment. We report the case of a 20-year-old woman with a 7-year history of a persistent erythematous plaque on the nose, previously misdiagnosed and refractory to multiple treatments, including systemic antimalarials and topical agents. Histopathological examination and direct immunofluorescence findings supported a diagnosis of DLE without systemic involvement. The patient was treated with topical crisaborole 2% ointment once daily in combination with hydroxychloroquine. Marked clinical improvement was observed after two months of treatment. Sustained remission was maintained during a seven-month follow-up period with continued crisaborole use and dose reduction of hydroxychloroquine, without recurrence or adverse effects. Crisaborole, a topical phosphodiesterase-4 inhibitor approved for atopic dermatitis, may represent a well-tolerated nonsteroidal therapeutic option for facial DLE, particularly in patients who are unresponsive to or intolerant of conventional treatments. Further studies are needed to clarify its efficacy and long-term safety in DLE.

#4

Association of Autoimmune Diseases With Pancreatic Cancer: A Nationwide Follow-Up Study From Sweden.

Cancer medicine2026 Mar

The incidence of pancreatic cancer (PC) and autoimmune diseases (ADs) has been increasing worldwide. While certain associations between specific ADs, such as pancreatitis, and PC have long been well confirmed, population-focused research investigating the broader spectrum of ADs and their relationship with PC risk remains limited. We implemented a cohort study based on population data to analyze the relationships between ADs and PC susceptibility. Diagnostic information on 43 ADs was obtained from the Swedish Inpatient Register (1964-2018), while cancer incidence and mortality data were sourced from the National Cancer Registry and Cause of Death Register starting in 1997. Relative cancer risks were quantified using standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs). Within the study's total population of 16.4 million, 1.1 million cases of ADs were identified, and 3257 patients were later diagnosed with PC accounting for 5.42% of all cancer cases in the cohort. The SIRs for PC in patients with ADs were 1.24 (men) and 1.19 (women); 12 ADs were positively correlated with the incidence of PC. The SMRs for PC in patients with ADs were 1.28 (men) and 1.22 (women); 15 ADs were positively correlated with PC mortality. When the follow-up time was less than 1 year, the overall risk of PC in patients with ADs was 3.88; over 10 years, the risk reached 1.12. We have newly discovered the relationship between several ADs and the risk of PC incidence and mortality, including discoid lupus erythematosus, lupoid hepatitis, giant-cell arteritis, and rheumatic fever. The results of this study back the notion that ADs may have a role in promoting the onset of PC.

#5

Pigmented Allergic Salute Sign in an Adult With Dark Skin: Clinical and Dermoscopic Features.

Cureus2026 Jan

Post-inflammatory hyperpigmentation due to chronic mechanical friction is well recognized in individuals with darker skin types, yet the pigmented variant of the allergic salute sign remains rarely documented. We report a 40-year-old woman with a persistent transverse hyperpigmented band over the nasal dorsum, associated with long-standing allergic rhinitis and recurrent conjunctivitis. She described habitual upward rubbing of the nose due to intense pruritus. Clinical examination revealed a sharply demarcated dark linear band above the nasal tip. Dermoscopy demonstrated a homogeneous dark pseudo-network with prominent follicular openings, consistent with post-inflammatory hyperpigmentation in Fitzpatrick phototype VI skin. Awareness of this presentation is essential to differentiate it from lichen planus pigmentosus or discoid lupus erythematosus. Management focuses on controlling allergic rhinitis, minimizing mechanical friction, and cautious use of depigmenting therapies. This case highlights the pigmented allergic salute sign as a distinctive marker of chronic allergic disease in patients with dark skin. Lupus erythematosus is a multisystem disorder that predominantly affects the skin. There are many types of lupus, including systemic lupus erythematosus (SLE), drug-induced lupus erythematosus, neonatal lupus erythematosus, and cutaneous lupus erythematosus. The most common types of cutaneous lupus erythematosus include acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus; discoid lupus erythematosus is a subtype of chronic cutaneous lupus erythematosus. Dr James Gilliam described the most commonly used classification of cutaneous lesions in lupus erythematosus. He distinguished lesions as either specific or nonspecific, based on the presence of interface dermatitis on histopathologic examination. Within the category of specific cutaneous lesions, he subdivided these into acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous erythematosus. Discoid lupus erythematosus is the most common subset of chronic cutaneous lupus erythematosus. Patients may or may not report photosensitivity, but lesions are frequently photodistributed and often exhibit secondary atrophy or scarring. Most patients with discoid lupus erythematosus do not have significant systemic disease. Discoid lupus erythematosus can also occur as a manifestation of SLE in approximately 20% of patients. Other less common variants of chronic cutaneous lupus erythematosus include hypertrophic lupus erythematosus, tumid lupus erythematosus, lupus erythematosus panniculitis (also known as lupus profundus), chilblain lupus erythematosus, oral discoid lupus erythematosus, and discoid lupus erythematosus lesions on the palms and soles.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.062 artigos no totalmostrando 198

2026

Comorbidities in Discoid Lupus: A Systematic Review and Meta-analysis of Prevalence and Association.

Dermatology and therapy
2026

Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.

Annals of plastic surgery
2026

Characteristics, Management, and Outcomes of Cutaneous Malignancies Arising Within Discoid Lupus Erythematosus: A Systematic Review.

Journal of cutaneous medicine and surgery
2026

Treatment of discoid lupus erythematosus with crisaborole.

The Journal of dermatological treatment
2026

Carrier of a pathogenic LAMB3 variant: Exploring the interface of genetic skin fragility and cutaneous autoimmunity.

JAAD case reports
2026

Association of Autoimmune Diseases With Pancreatic Cancer: A Nationwide Follow-Up Study From Sweden.

Cancer medicine
2026

Pigmented Allergic Salute Sign in an Adult With Dark Skin: Clinical and Dermoscopic Features.

Cureus
2026

A Diagnostic Pitfall: Lupus Mastitis Presenting Before Diagnosis of Systemic Lupus Erythematosus.

Case reports in rheumatology
2026

Lupus Erythematosus Panniculitis Patients With Overlying Discoid Lupus Erythematosus Have Higher Rates of Head and Neck Involvement Than Those Without.

The Journal of dermatology
2026

Dermoscopy of Lichen Planus Follicularis Tumidus: A Case Report With Pattern Analysis and Literature Review.

Clinical case reports
2026

In vivo differentiation of scarring alopecia using line-field confocal optical coherence tomography: a pilot study.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2026

Generalized verrucous discoid lupus erythematosus.

Journal of the European Academy of Dermatology and Venereology : JEADV
2025

A Case Report of Discoid Lupus Erythematosus Mimicking Skin Infection.

Reports (MDPI)
2026

Rapid clinical response in refractory discoid lupus erythematosus treated with anifrolumab.

Anais brasileiros de dermatologia
2026

Line Field Confocal Optical Coherence Tomography (LC-OCT) Features of Primary Cicatricial Alopecias.

International journal of dermatology
2026

Cheilitis: a comprehensive review and a new clinical classification proposal. Part 1: Isolated cheilitis.

Italian journal of dermatology and venereology
2025

Xanthomatous Discoid Lupus Erythematosus: An Unusual Histopathological Variant and Review of Reported Cases.

Cureus
2025

A Rare Case of Coexistence: Discoid Lupus Erythematosus and Sturge-Weber Syndrome.

Clinical case reports
2026

A Unique Case of Nodular Cutaneous Lupus Mucinosis With Discoid Lupus Erythematosus-Like Changes in a Patient With Systemic Lupus Erythematosus and Sjögren Syndrome.

The Journal of dermatology
2025

Cheilitis: a comprehensive review and a new clinical classification proposal. Part 2: Cheilitis associated with dermatological diseases, systemic diseases, or drug reactions.

Italian journal of dermatology and venereology
2025

Discoid Lupus Erythematosus: A Comparative Evaluation Between Line-Field Confocal Optical Coherence Tomography and Histology in a Multicenter Cross-Sectional Study.

Experimental dermatology
2025

A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report.

Clinical, cosmetic and investigational dermatology
2025

Rare coexistence of generalized pustular psoriasis and discoid lupus erythematosus with worsening of lupus lesions after bimekizumab therapy: a case report.

European journal of dermatology : EJD
2025

Trichoscopic Differentiation in Alopecia: Retrospective Case Series Comparing Lichen Planopilaris, Discoid Lupus Erythematosus, and Alopecia Areata.

JMIR dermatology
2025

Implications of Podoplanin Overexpression in the Malignant Transformation of Oral Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.

Cancers
2025

Identification of T cell stress response state (TSTR) and key genes related to T cells in discoid lupus erythematosus.

Scientific reports
2025

Discoid lupus erythematosus and its progression to systemic lupus erythematosus across age groups: a systematic review.

Journal of medicine and life
2026

Topical Cyclosporine 5% in Pentravan for Refractory Discoid Lupus Erythematosus: Clinical Remission in a 15 Patients Case Series.

International journal of dermatology
2025

Koebner Phenomenon Induced by Eyeglasses in a Patient With Discoid Lupus Erythematosus.

Case reports in dermatological medicine
2025

Erbium-doped nonablative fractional laser therapy for postinflammatory hyperpigmentation and atrophic scarring due to discoid lupus erythematosus in a patient with systemic lupus erythematosus.

JAAD case reports
2025

Crosstalk Between Keratinocytes and T Cells in Ulcerative Oral Mucosal Diseases: Mechanisms of Epithelial Dysfunction and Therapeutic Perspectives.

Journal of inflammation research
2025

Review of Promising Off-Label Use of Deucravacitinib.

International journal of molecular sciences
2025

A systematic review of procedural modalities in the treatment of lichen planopilaris, frontal fibrosing alopecia, and discoid lupus erythematosus.

Lasers in medical science
2025

Dyspigmentation and scarring in cutaneous lupus erythematosus.

Lupus science &amp; medicine
2026

Long-Term Risk of Dermatoses Following Sulfur Mustard Exposure: A Retrospective Cohort Study.

International journal of dermatology
2025

Unilateral discoid lupus erythematosus: two atypical cases with distinct presentations.

Dermatology online journal
2026

Treatment of Cutaneous Lupus Erythematosus: An Evidence-Based Review.

Dermatology (Basel, Switzerland)
2025

Micronutrient levels and thyroid functions in scarring alopecias: Do they play a role in disease pathogenesis?

Cutaneous and ocular toxicology
2025

Targeting JAK/STAT signaling: ruxolitinib cream in the management of concurrent vitiligo and discoid lupus erythematosus.

Dermatology reports
2026

Eyelid Involvement as a Standalone Ophthalmological Finding of Lupus.

Ophthalmic plastic and reconstructive surgery
2025

Comparison of the Efficacy of Intralesional Ascorbic Acid Mesotherapy and Intralesional Tranexamic Acid in Treating Melasma in the Skin of Colour Population.

Cureus
2025

Wolf and the Dagger: A Rare Overlap.

Cureus
2025

Isotopic Responses Following Herpes Zoster.

Journal of drugs in dermatology : JDD
2025

A Rare Case of Lichen Planus/Discoid Lupus Erythematosus Overlap Syndrome and Its Successful Treatment.

Clinical case reports
2025

Discoid lupus erythematosus with cornoid lamellation.

European journal of dermatology : EJD
2025

A Single Centre Cross-Sectional Observational Study on Dermatoscopy of Oral Mucosal Disorders and Histopathological Correlation in Tertiary Care Centre from Central India.

Indian journal of dermatology
2025

Discoid Lupus Flare with Chondritis Triggered by Eaton Fire Case Report.

Current rheumatology reviews
2025

Parry-Romberg Syndrome with Localized Plaque Morphea and Localized Discoid Lupus Erythematosus: A Case Report of a Rare Overlap.

Indian dermatology online journal
2025

Recognizing ophiasis pattern in discoid lupus: a rare diagnostic challenge.

Dermatology reports
2025

Trichopathology of Cicatricial Alopecia.

International journal of trichology
2025

Trends and collaborations in discoid lupus erythematosus research: a bibliometric analysis from 2010 to 2024.

Frontiers in medicine
2025

[Recent advances in the relationship and mechanistic study of hyperglycemia and oral potentially malignant disorders].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
2025

Demodex Infestation in Discoid Lupus Erythematosus: A Histopathologic Study.

The American Journal of dermatopathology
2025

Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report.

SAGE open medical case reports
2025

A case of vitiligo secondary to discoid lupus erythematosus treated with tofacitinib.

Medicine
2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus.

Journal of visualized experiments : JoVE
2025

C1q monogenic lupus: a case series and review.

Rheumatology advances in practice
2025

Immunohistochemical Expression of Plasmacytoid Dendritic Cell Markers in Cutaneous Lupus Erythematosus Subtypes in Skin of Color.

The American Journal of dermatopathology
2025

The patterns of recurrence in cutaneous lupus erythematosus: A retrospective analysis of subacute cutaneous lupus erythematosus and discoid lupus erythematosus flares.

Journal of the American Academy of Dermatology
2025

Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.

Archives of dermatological research
2025

Outcomes following single level posterior lumbar fusion in patients with systemic and discoid lupus: A retrospective national database study.

North American Spine Society journal
2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus.

Journal of visualized experiments : JoVE
2025

Discoid Lupus Erythematosus Induced by Teriflunomide in a Patient With Multiple Sclerosis: A Case Report.

International journal of rheumatic diseases
2025

Anifrolumab for refractory discoid lupus: Two case reports of successful outcomes in Saudi Arabia.

Medicine
2025

Facial follicular porokeratosis simulating discoid lupus erythematosus in an African American woman.

JAAD case reports
2025

Progressive repigmentation of hypopigmented lesions in discoid lupus erythematosus with anifrolumab: A report of two cases.

Lupus
2025

Adjunctive anifrolumab for recalcitrant discoid lupus erythematosus in the setting of systemic lupus erythematosus: A case report.

JAAD case reports
2025

Scarring Alopecia and Risk of Skin Cancer: A Literature Review.

Skin appendage disorders
2025

From Prescription to Predicament: A Case of Semaglutide-Induced Discoid Lupus Erythematosus in an Adult Male Patient.

Cureus
2025

Combination Therapy With Voclosporin and Anifrolumab in Two Patients With Lupus Nephritis and Discoid Lupus Erythematosus.

Cureus
2025

The application of direct immunofluorescence in the pathological diagnosis of oral mucosal diseases: Series of 116 cases.

Pathology, research and practice
2025

Use of Deucravacitinib in Cutaneous Lupus Erythematosus: Two Patient Experiences at a Combined Rheumatology-Dermatology Clinic.

International journal of dermatology
2025

Flare of bullous lupus erythematosus in patients treated with anifrolumab for discoid lupus erythematosus: 2 cases.

JAAD case reports
2025

Comedonal Plaques With Scarring Alopecia on the Scalp: A Case Report.

Cureus
2025

Eosinophils are rare or absent in discoid lupus erythematosus.

Journal of the American Academy of Dermatology
2025

Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population.

Lupus
2025

Spatial Transcriptomics Reveals Differential Inflammatory Pathways in Discoid Lupus Erythematosus and Lichen Planus.

The Journal of investigative dermatology
2025

Imaging Findings of Lupus Mastitis: A Systematic Review of Case Studies.

Cureus
2025

Representation of skin of color in patient education materials for discoid lupus erythematosus.

Archives of dermatological research
2025

Can Dermoscopy Be a Useful Follow-Up Tool in Patients with Discoid Lupus Treated with Anifrolumab?

Diagnostics (Basel, Switzerland)
2025

Synovitis and its association with elevated circulating interferons and hydroxychloroquine response in discoid lupus erythematosus: a cross-sectional study.

Rheumatology international
2025

An uncommon presentation of discoid lupus suggesting systemic evolution.

SAGE open medical case reports
2025

Tattoo-induced hypertrophic discoid lupus erythematosus in a patient with vitiligo.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2025

Discoid lupus erythematosus presenting as an unusual giant plaque on face.

Indian journal of dermatology, venereology and leprology
2024

Evaluating biomarkers in canine cytotoxic interface dermatitis reactions to account for clinical and histopathological similarities and differences.

Frontiers in veterinary science
2025

Clinical and Trichoscopic Patterns of Discoid Lupus Erythematosus of Scalp in Patients with Systemic Lupus Erythematosus: An Observational Study.

Indian journal of dermatology
2025

Case Report: Severe Immune-Related Adverse Event Under Pembrolizumab Therapy for Discoid Lupus Erythematosus-Related Squamous Cell Carcinoma.

International journal of rheumatic diseases
2025

Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review.

Expert opinion on drug metabolism &amp; toxicology
2025

A scientometric study on research trends and characteristics of discoid lupus erythematosus.

Journal of dental sciences
2025

Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology.

Pharmaceutics
2025

In Vivo Characterization of the Inflammatory Infiltrate in Discoid Lupus Erythematosus (DLE) by Line-Field Confocal Optical Coherence Tomography (LC-OCT).

Dermatology practical &amp; conceptual
2025

Solitary verrucous plaque on the chin: hypertrophic discoid lupus erythematosus⋆.

Anais brasileiros de dermatologia
2025

Epidemiology of discoid lupus erythematosus among adults in the United States: a cross-sectional analysis.

International journal of dermatology
2025

Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report.

SAGE open medical case reports
2025

The morphological spectrum of cheilitis.

Journal of the American Academy of Dermatology
2025

Application of Ultraviolet-Induced Fluorescence Trichoscopy (UVFT) in Hair and Scalp Diseases.

Dermatology and therapy
2024

Treatment of recalcitrant discoid lupus erythematosus with roflumilast 0.3% cream following suboptimal response to anifrolumab and improvement of hypopigmentation.

JAAD case reports
2024

Large-scale global retrospective study on the interaction between ancestry and risk of comorbid autoimmune diseases in patients with pemphigus.

Scientific reports
2024

Secukinumab-Aggravated Disseminated Discoid Lupus Erythematosus Misdiagnosed as Psoriasis.

Cureus
2025

Ruxolitinib cream for discoid lupus erythematosus: An open-label pilot study of 10 subjects.

Journal of the American Academy of Dermatology
2025

Spatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology.

JID innovations : skin science from molecules to population health
2024

Successful treatment of discoid lupus erythematosus with tapinarof 1% cream monotherapy.

JAAD case reports
2025

Acneiform lesions in a 57-year-old woman.

International journal of dermatology
2025

Histopathologic Comparisons of Discoid Lupus Erythematosus and Folliculotropic Mycosis Fungoides in a Series of 43 Cases.

Journal of cutaneous pathology
2024

Imatinib associated discoid lupus erythematosus in a patient with chronic myeloid leukemia.

JAAD case reports
2024

Oral lichen planus-like lesions in skin of color: a review.

International journal of dermatology
2025

[Translated article] Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune Dermatoses.

Actas dermo-sifiliograficas
2024

Trichoscopy of Discoid Lupus Erythematosus in Caucasian Scalp: A Review.

Skin appendage disorders
2024

Treatment of discoid lupus with lenalidomide and anifrolumab: Case report and review of the literature.

Lupus
2024

Discoid Lupus Erythematosus.

The New England journal of medicine
2024

Diagnostic dilemma in pigmented basal cell carcinoma: A case report.

Journal of education and health promotion
2024

Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in a cohort of Colombian population.

Clinical rheumatology
2025

Cutaneous Squamous Cell Carcinoma Arising Within Discoid Lupus Erythematosus-Utilizing Acitretin and Hydroxychloroquine to Preoperatively Decrease Lupus Burden.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2024

Comorbidities associated with discoid lupus erythematosus: A case-control study in the All of Us Research Program.

Experimental dermatology
2024

Mucosal Cancers Arising in Potentially Malignant Lesions of the Oral Mucosa Are Marjolin Ulcers: New Insights Into Old Concepts.

Dermatology practical &amp; conceptual
2024

Surgical Excision Combined with Photodynamic Therapy for Squamous Cell Carcinoma Arising in Lupus Vulgaris.

Clinical, cosmetic and investigational dermatology
2024

Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy.

Cureus
2024

Distinct Patient Disease Profiles in Discoid Lupus Erythematosus and Subacute Lupus Erythematosus: A Retrospective Study.

Journal of cutaneous medicine and surgery
2024

Area Deprivation and Disease Severity in Adult Patients With Discoid Lupus Erythematosus.

JAMA dermatology
2024

Trichoscopy of Discoid Lupus Erythematosus in the Black Scalp: A Literature Review.

Skin appendage disorders
2024

Disseminated Hypertrophic Discoid Lupus Erythematosus in a Patient with Vitiligo: A Case Report and Literature Review.

Clinical, cosmetic and investigational dermatology
2024

Lichen Planus of the Lip-Case Series and Review of the Literature.

Medicina (Kaunas, Lithuania)
2024

Many faces of cutaneous leishmaniasis.

Postgraduate medical journal
2024

Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab.

BMJ case reports
2024

Discoid lupus erythematosus successfully treated with deucravacitinib.

JAAD case reports
2024

Efficacy of topical tacrolimus monotherapy against pediatric discoid lupus erythematosus.

The Journal of dermatology
2025

A benign masquerade of eyelid malignancy: Discoid lupus erythematosus.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2024

Lupus Erythematosus Tumidus as a Distinct Uncommon Subtype of Cutaneous Lupus Erythematosus: A Case Report and Review.

Cureus
2024

Reflectance confocal microscopy in pediatric patients with Sweet's syndrome: a useful method to differentiate from discoid lupus erythematosus.

Archives of dermatological research
2024

Discoid lupus erythematosus affecting the scalp.

JAAD case reports
2023

Halting the Progression of Cicatricial Alopecia with Injectable Platelet-Rich Fibrin.

International journal of trichology
2024

Systemic correlates of cutaneous manifestations of lupus erythematosus.

International journal of dermatology
2024

Dermoscopy to differentiate clinically similar inflammatory and neoplastic skin lesions.

Italian journal of dermatology and venereology
2024

The role of thymic stromal lymphopoietin in cutaneous disorders.

Archives of dermatological research
2024

Trichoscopic Features of Scalp Discoid Lupus Erythematosus versus Lichen Planopilaris: A Systematic Review.

Clinical, cosmetic and investigational dermatology
2024

Efficacy of anifrolumab in long-term intractable alopecia due to discoid lupus erythematosus.

Modern rheumatology case reports
2024

Treatment With Voclosporin and Anifrolumab in a Patient With Lupus Nephritis and Refractory Discoid Lupus Erythematosus: A Case Report and Literature Review.

Cureus
2023

Linear discoid lupus erythematous simulating en coup de sabre morphea in a female chronic granulomatous disease carrier.

Dermatology online journal
2025

Screening of Genes Associated with Immune Infiltration of Discoid Lupus Erythematosus Based on Weighted Gene Co-expression Network Analysis.

Biochemical genetics
2024

Oral lesions in adult- and juvenile-onset systemic lupus erythematosus patients: A case series report.

Dental and medical problems
2023

Atorvastatin-induced Lupus Erythematosus Tumidus: A Case Report and Literature Review.

Acta dermatovenerologica Croatica : ADC
2024

A gyrate pattern of discoid lupus erythematosus.

The Journal of dermatology
2024

Case report: Cannabinoid therapy for discoid lupus erythematosus in a dog.

Frontiers in veterinary science
2024

Painful Limb Ulcers: A Case Report on Ulcerative Discoid Lupus Erythematosus.

Cureus
2024

Papulonodular mucinosis with features of discoid lupus erythematosus.

JAAD case reports
2024

An impressive case of Rowell syndrome with extensive mucosal involvement successfully treated with anifrolumab.

JAAD case reports
2023

Discoid Lupus Erythematosus along the Lines of Blaschko in an Adult: A Case Report.

Indian journal of dermatology
2024

Trichoscopic findings of discoid lupus erythematosus.

Journal of the European Academy of Dermatology and Venereology : JEADV
2024

Squamous Cell Carcinoma Arising From Discoid Lupus Erythematosus.

Journal of cutaneous medicine and surgery
2024

Concentrated growth factor therapy as cosmetic treatment in discoid lupus erythematosus.

The Journal of dermatology
2024

Atypical Dyschromia in Skin of Color.

Journal of drugs in dermatology : JDD
2024

Interesting Mucocutaneous Manifestations in COVID-19 Infection or Vaccination Confirmed by Histopathology: A Case Series.

Case reports in dermatology
2024

The treatment of primary cicatricial alopecia is challenging.

Journal of the American Academy of Dermatology
2023

Uncommon manifestation of discoid lupus erythematosus in a human immunodeficiency virus patient.

Indian journal of sexually transmitted diseases and AIDS
2024

Optical coherence tomography: Promising imaging technique for the diagnosis of oral mucosal diseases.

Oral diseases
2024

Morphea-like discoid lupus erythematosus in a patient with a history of polyacrylamide gel injection: A case report.

Journal of cosmetic dermatology
2023

Prevalence of Oral Submucous Fibrosis With Other Oral Potentially Malignant Disorders: A Clinical Retrospective Study.

Cureus
2023

Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration.

Investigative ophthalmology &amp; visual science
2024

Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.

The Journal of investigative dermatology
2024

Case report of canine discoid lupus erythematosus in Guatemala.

Veterinary medicine and science
2023

Cornu Cutaneum: Case Reports of Patients With a Cutaneous Horn Associated With Either a Verruca Vulgaris or an Inverted Follicular Keratosis and a Review of the Etiologies of Cutaneous Horns.

Cureus
2023

Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus.

Medicina (Kaunas, Lithuania)
2024

Letter re: Lupus erythematosus masquerading as acneiform lesions: two cases and review of the literature.

Lupus
2023

A Rare Manifestation of Discoid Lupus Erythematosus Solely in the Lower Eyelid of a Young Man.

Cureus
2023

Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis.

JAAD case reports
2023

My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive  dermatomyositis overlapping with discoid lupus erythematosus in an adult patient.

JAAD case reports
2024

Efficacy of upadacitinib in a case of resistant lupus erythematosus tumidus.

Journal of the European Academy of Dermatology and Venereology : JEADV
2023

Anifrolumab for Adolescent Discoid Lupus Erythematosus.

JAMA network open
2023

Treatment of Discoid Lupus Erythematosus with Upadacitinib: A Case Report.

Clinical, cosmetic and investigational dermatology
2024

Change in disease activity needed for meaningful change in cutaneous lupus by patient characteristic: A retrospective analysis of a longitudinal database.

Journal of the American Academy of Dermatology
2023

Lupus Erythematosus Profundus with Multiple Overlying Cutaneous Ulcerations: A Rare Case.

Clinical, cosmetic and investigational dermatology
2023

Raman spectroscopy and mass spectrometry identifies a unique group of epidermal lipids in active discoid lupus erythematosus.

Scientific reports
2023

A mimicker of inflammatory breast carcinoma: Lupus mastitis and evolving imaging features.

Journal of clinical ultrasound : JCU
2023

Discoid lupus erythematosus of the nail treated with thalidomide.

JAAD case reports
2024

Clinical epidemiology of tumid lupus erythematosus: A retrospective review of 179 patients.

Journal of the American Academy of Dermatology
2023

The Role of Lasers in Connective Tissue and Inflammatory Dermatoses: A 10-Year Retrospective Review of 60 Patients in a UK Tertiary Laser Clinic.

Indian dermatology online journal
2024

Discoid lupus erythematosus associated with chronic granulomatous disease.

Dermatology reports
2023

The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus-A Pilot Study.

Journal of clinical medicine
2023

Risk and prevalence of oral cancer in patients with different types of lupus erythematosus: a systematic review and meta-analysis.

Oral surgery, oral medicine, oral pathology and oral radiology
2023

Misdiagnosed Progressive Multifocal Leukoencephalopathy (PML) in an HIV-Negative Patient With Discoid Lupus: A Case Report.

Cureus
2023

The dermatoscope in the hair clinic: Trichoscopy of scarring and nonscarring alopecia.

Journal of the American Academy of Dermatology
2024

Cross-sectional study to evaluate the utility of elastic tissue staining in primary cicatricial alopecia.

Journal of clinical pathology
2023

Evaluation of the Involvement of Heme Oxygenase-1 Expression in Discoid Lupus Erythematosus Lesions.

Antioxidants (Basel, Switzerland)
2023

Alopecia secondary to severe discoid lupus responding to anifrolumab.

International journal of women's dermatology
2023

Increased risk of depression in patients with discoid lupus erythematosus: a nested, case-control study in the All of Us Research Program.

The British journal of dermatology
2023

Discoid Lupus Erythematosus of the Palms.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2023

Clinical, histological and direct immunofluorescence features in oral mucosal patches striae diseases with malignant potential.

Journal of dental sciences
2023

Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review.

Cureus
2023

Histopathologic Spectrum of Alopecias Seen in a Jamaican Setting.

The American Journal of dermatopathology
2023

Squamous Cell Carcinoma Arising in Discoid Lupus Erythematosus of the Nail Unit.

Skin appendage disorders
2023

Intralesional Certolizumab for Refractory Lupus Pernio.

JAMA dermatology
2023

The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.

Clinical rheumatology
2023

Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: More evidence will be needed: Authors reply.

Journal of the American Academy of Dermatology
2023

Ocular Discoid Lupus Erythematosus: More Than what Meets The Eye.

Indian dermatology online journal
2023

Unusual case of adult-onset cutaneous lupus erythematosus mimicking early mycosis fungoides.

Oxford medical case reports
2023

A Case of Mixed Connective Tissue Disease That Transformed Into Systemic Lupus Erythematosus After a Long Clinical Course.

Cureus
2023

Sarcoidosis Coexisting With Distinct Forms of Alopecia on the Scalp: A Case Series.

The American Journal of dermatopathology
2023

Improvement in mucosal discoid lupus erythematosus with anifrolumab.

Clinical and experimental dermatology
Ver todos os 1.062 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Lúpus eritematoso discoide.

É de uma associação que acompanha esta doença? Fale com a gente →

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Protocolo oficial relacionado (Ministério da Saúde)PCDT: Lúpus Eritematoso Sistêmico

Existe um documento oficial para "Lúpus Eritematoso Sistêmico". Ele pode não cobrir esta forma específica da doença — confira no texto do protocolo antes de contar com ele.

Respostas geradas por IA a partir das fontes citadas

É uma doença autoimune crônica da pele que causa erupções avermelhadas e com descamação no rosto, orelhas e couro cabeludo. Essas lesões podem levar ao surgimento de cicatrizes atróficas permanentes e alteração na pigmentação da pele.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

10 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:90281
    Orphanet
  2. GARD:19131
    GARD (NIH)
  3. Q1228801
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Lúpus eritematoso discoide. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/lupus-eritematoso-discoide

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Lúpus eritematoso discoide
Compêndio · Raras BR

Lúpus eritematoso discoide

ORPHA:90281 · MONDO:0019558
🇧🇷 Brasil SUS
CEAF
1BAzatioprina
Geral
Prevalência
1-5 / 10 000
CID-10
L93.0 · Lúpus eritematoso discóide
CID-11
Ensaios
11 ativos
Início
Adolescent, Adult, Childhood, Elderly
Prevalência
30.0 (Worldwide)
MedGen
UMLS
C0024138
Repurposing
3 candidatos
dexamethasone — glucocorticoid receptor agonist
dexamethasone-acetate
prednisolone-sodium-phosphate
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Medicamentos aprovados FDA
fonte: FDA OpenFDA
Rara